JAN 13, 2022 9:00 AM PST

Discovering the FDA-cleared Acuitas AMR Gene Panel: Building a Case for Clinical Utility

Sponsored by: OpGen
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Associate Professor of Pathology - Johns Hopkins University School of Medicine and Director of the Medical Bacteriology and Infectious Disease Sequencing Laboratories - Johns Hopkins Hospital
    BIOGRAPHY
  • Associate Medical Director - Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center / Associate Professor of Pathology at Harvard Medical School
    BIOGRAPHY

Abstract
Date:  January 13, 2022
Time: 9:00am (PST),  12:00pm (EST)
 
Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug-resistant organisms. The guidance highlighted the need to define mechanisms of antimicrobial resistance (AMR) to guide and tailor therapy. In this presentation, we will describe the newly FDA-cleared Acuitas AMR Gene Panel and review the multicenter diagnostic clinical trial data. The Acuitas AMR Gene Panel is a qualitative, multiplex nucleic acid‐based in vitro diagnostic test for detection and differentiation of 28 AMR markers associated with not susceptible results (i.e., intermediate or resistant) to one or more antimicrobial agents among cultured isolates of Enterobacterales, Pseudomonas aeruginosa, and Enterococcus faecalis. The Acuitas AMR Gene Panel has the potential to fill the gap that other rapid molecular tools cannot by detecting a broad array of molecular markers associated with up to 9 classes/subclasses of antimicrobials. The clinical utility of the diagnostic will be presented through a case-based format.
 
Learning Objectives
  • Describe the FDA-cleared Acuitas AMR Gene Panel.
  • Define the performance characteristics of the Acuitas AMR Gene panel.
  • Discover the potential utility of the Acuitas AMR Gene panel to impact patient care.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
JUN 16, 2022 10:00 AM PDT
JUN 16, 2022 10:00 AM PDT
Date: June 16, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources